These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37537844)

  • 21. Neuroblastoma-associated Opsoclonous Myoclonous Ataxia Syndrome: Profile and Outcome Report on 15 Egyptian Patients.
    Elzomor H; El Menawi S; Elawady H; Elkinaai N; Elshafie M; Refaat A; Ghareeb H; Fawzy M
    J Pediatr Hematol Oncol; 2023 Mar; 45(2):e194-e199. PubMed ID: 35462382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.
    Raffaghello L; Conte M; De Grandis E; Pistoia V
    Eur J Paediatr Neurol; 2009 May; 13(3):219-23. PubMed ID: 18571942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inaugural Patient-Reported Registry of Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome: Presentation, Diagnosis, and Treatment of 194 Patients.
    Jimenez Giraldo S; Michaelis M; Kerr L; Cortina C; Zhang B; Gorman MP
    Pediatr Neurol; 2024 Sep; 158():128-134. PubMed ID: 39042987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
    Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
    Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
    Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
    Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An unusual case of opsoclonus-myoclonus-ataxia syndrome associated neuroblastoma: High-risk disease requiring immunotherapy.
    Stiefel J; Basu E; Meyer R; Kaur G; Khakoo Y
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28393. PubMed ID: 32798258
    [No Abstract]   [Full Text] [Related]  

  • 27. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
    Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
    Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
    Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
    Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK Cell-mediated Neuroblastoma Cell Lysis is Enhanced by IgG From Patients With Pediatric Opsoclonus-Myoclonus Syndrome.
    Zar T; Tschernatsch M; Hero B; Lang B; Preissner KT; Blaes F
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e176-e179. PubMed ID: 33060390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropsychological profile in opsoclonus-myoclonus-ataxia syndrome presenting as neuroblastic tumours].
    Bravo J; López-Almaraz R; Mateos M; Díaz L; Hernández-Expósito S
    Rev Neurol; 2016 Mar; 62(6):249-57. PubMed ID: 26961423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain Volumes in Opsoclonus-Myoclonus Ataxia Syndrome: A Longitudinal Study.
    Almudhry M; Wagner MW; Longoni G; Yea C; Vidarsson L; Ertl-Wagner B; Yeh EA
    J Child Neurol; 2024 Mar; 39(3-4):129-134. PubMed ID: 38544431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection-Associated Opsoclonus: A Retrospective Case Record Analysis and Review of Literature.
    Saini L; Dhawan SR; Madaan P; Suthar R; Saini AG; Sahu JK; Sankhyan N
    J Child Neurol; 2020 Jun; 35(7):480-484. PubMed ID: 32216501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric opsoclonus-myoclonus-ataxia syndrome: Experience from a tertiary care university hospital.
    Huddar A; Bindu PS; Nagappa M; Bharath RD; Sinha S; Mathuranath PS; Taly AB
    Neurol India; 2018; 66(5):1332-1337. PubMed ID: 30232999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
    Gupta A; Kundal R; Pandey M
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroblastoma, opsoclonus-myoclonus ataxia syndrome and neonatal lupus with congenital heart block: is there an association?
    Sharawat IK; Saini AG; Kasinathan A; Mandava SS; Sankhyan N
    Lupus; 2018 Dec; 27(14):2298-2299. PubMed ID: 30282557
    [No Abstract]   [Full Text] [Related]  

  • 37. Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
    Deniz A; Alikılıç D; Öztürk M; Karaca Ö; Güngör M; Kara B
    J AAPOS; 2023 Apr; 27(2):110-112. PubMed ID: 36736453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of identical B-cell clone in both cerebrospinal fluid and tumor tissue in a patient with opsoclonus-myoclonus syndrome associated with neuroblastoma.
    Noguchi K; Ikawa Y; Takenaka M; Sakai Y; Fujiki T; Kuroda R; Ikeda H; Nakada S; Nomura K; Sakai S; Fukuda M; Araki R; Takahashi Y; Wada T
    Pediatr Hematol Oncol; 2023 May; 40(4):363-370. PubMed ID: 36125271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opsoclonus myoclonus ataxia syndrome, ovarian teratoma and anti-NMDAR antibody: an 'unresolved' mystery.
    Miraclin AT; Mani AM; Sivadasan A; Nair A; Christina M; Gojer AR; Milton S; Jude Prakash JA; Benjamin RN; Prabhakar AT; Mathew V; Aaron S
    BMJ Neurol Open; 2023; 5(1):e000414. PubMed ID: 37396795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer and Autoimmunity: Paraneoplastic Neurological Disorders Associated With Neuroblastic Tumors.
    Mitchell WG; Blaes F
    Semin Pediatr Neurol; 2017 Aug; 24(3):180-188. PubMed ID: 29103425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.